Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Clinical trial NCT00991510 · TERMINATED

Trial details

NCT number: NCT00991510
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Stable Renal Transplant Recipients

Start date: 2009-08-01
Primary completion: 2010-10-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.